# Annaly Capital Management Inc: financial statements, quarterly

NLY · NYSE · CIK 1043219 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nly.md) · [Financials](/companies/nly/financials.md) · [Filings](/companies/nly/filings.md) · [Insiders](/companies/nly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [1,047](/filings/0001628280-24-044566.md) | [1,044 d](/filings/0001043219-26-000013.md) | [1,101](/filings/0001628280-25-023811.md) | [1,124](/filings/0001628280-25-036724.md) | [1,216](/filings/0001043219-25-000012.md) | [1,152 d](/filings/0001043219-26-000013.md) | [1,097](/filings/0001043219-26-000028.md) | [1,146](/filings/0001043219-26-000058.md) | [1,257](/filings/0001043219-25-000012.md) | [1,324 d](/filings/0001043219-26-000013.md) | [1,272](/filings/0001043219-26-000028.md) | [1,324](/filings/0001043219-26-000058.md) |
| Income tax | $m | [12.4](/filings/0001628280-24-044566.md) | [1.7 d](/filings/0001043219-26-000013.md) | [(0.9)](/filings/0001628280-25-023811.md) | [11.9](/filings/0001628280-25-036724.md) | [(6.1)](/filings/0001043219-25-000012.md) | [10.4 d](/filings/0001043219-26-000013.md) | [8.3](/filings/0001043219-26-000028.md) | [0.4](/filings/0001043219-26-000058.md) | [(7.8)](/filings/0001043219-25-000012.md) | [(7.8) d](/filings/0001043219-26-000013.md) | [(1.5)](/filings/0001043219-26-000028.md) | [6.9](/filings/0001043219-26-000058.md) |
| Net income | $m | [(562)](/filings/0001628280-24-044566.md) | [(404) d](/filings/0001043219-26-000013.md) | [463](/filings/0001628280-25-023811.md) | [(9.5)](/filings/0001628280-25-036724.md) | [66.4](/filings/0001043219-25-000012.md) | [482 d](/filings/0001043219-26-000013.md) | [124](/filings/0001043219-26-000028.md) | [57.1](/filings/0001043219-26-000058.md) | [832](/filings/0001043219-25-000012.md) | [1,013 d](/filings/0001043219-26-000013.md) | [283](/filings/0001043219-26-000028.md) | [823](/filings/0001043219-26-000058.md) |
| Diluted EPS | $ per share | [(1.21)](/filings/0001628280-24-044566.md) | not reported | [0.85](/filings/0001628280-25-023811.md) | [(0.09)](/filings/0001628280-25-036724.md) | [0.05](/filings/0001043219-25-000012.md) | not reported | [0.15](/filings/0001043219-26-000028.md) | [0.03](/filings/0001043219-26-000058.md) | [1.20](/filings/0001043219-25-000012.md) | not reported | [0.33](/filings/0001043219-26-000028.md) | [1.06](/filings/0001043219-26-000058.md) |
| Basic EPS | $ per share | [(1.21)](/filings/0001628280-24-044566.md) | not reported | [0.85](/filings/0001628280-25-023811.md) | [(0.09)](/filings/0001628280-25-036724.md) | [0.05](/filings/0001043219-25-000012.md) | not reported | [0.15](/filings/0001043219-26-000028.md) | [0.03](/filings/0001043219-26-000058.md) | [1.21](/filings/0001043219-25-000012.md) | not reported | [0.33](/filings/0001043219-26-000028.md) | [1.06](/filings/0001043219-26-000058.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [1.4](/filings/0001628280-24-005115.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [89.6](/filings/0001628280-24-044566.md) | [93.2](/filings/0001043219-26-000013.md) | [91.5](/filings/0001628280-25-023811.md) | [93.7](/filings/0001628280-25-036724.md) | [102](/filings/0001043219-25-000012.md) | [104](/filings/0001043219-26-000013.md) | [105](/filings/0001043219-26-000028.md) | [112](/filings/0001043219-26-000058.md) | [126](/filings/0001043219-25-000012.md) | [136](/filings/0001043219-26-000058.md) | [139](/filings/0001043219-26-000028.md) | [144](/filings/0001043219-26-000058.md) |
| Total liabilities | $bn | [79.0](/filings/0001628280-23-036438.md) | [81.9](/filings/0001628280-25-005451.md) | [80.0](/filings/0001628280-24-020047.md) | [82.4](/filings/0001628280-24-033212.md) | [89.0](/filings/0001628280-24-044566.md) | [90.9](/filings/0001043219-26-000013.md) | [92.0](/filings/0001628280-25-023811.md) | [98.7](/filings/0001628280-25-036724.md) | [111](/filings/0001043219-25-000012.md) | [119](/filings/0001043219-26-000058.md) | [122](/filings/0001043219-26-000028.md) | [127](/filings/0001043219-26-000058.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [10.6](/filings/0001628280-23-036438.md) | [11.3](/filings/0001628280-25-005451.md) | [11.4](/filings/0001628280-24-020047.md) | [11.2](/filings/0001628280-24-033212.md) | [12.4](/filings/0001628280-24-044566.md) | [12.6](/filings/0001043219-26-000013.md) | [13.0](/filings/0001628280-25-023811.md) | [13.4](/filings/0001628280-25-036724.md) | [14.9](/filings/0001043219-25-000012.md) | [16.1](/filings/0001043219-26-000058.md) | [16.3](/filings/0001043219-26-000028.md) | [16.9](/filings/0001043219-26-000058.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,871 d](/filings/0001628280-24-044566.md) | [379 d](/filings/0001043219-26-000013.md) | [1,698](/filings/0001628280-25-023811.md) | [477 d](/filings/0001628280-25-036724.md) | [(1,673) d](/filings/0001043219-25-000012.md) | [2,808 d](/filings/0001043219-26-000013.md) | [(156)](/filings/0001043219-26-000028.md) | [181 d](/filings/0001043219-26-000058.md) | [24.1 d](/filings/0001043219-25-000012.md) | [644 d](/filings/0001043219-26-000013.md) | [(1,401)](/filings/0001043219-26-000028.md) | [1,619 d](/filings/0001043219-26-000058.md) |
| Dividends paid | $m | [322](/filings/0001628280-24-044566.md) | [3.4 d](/filings/0001628280-25-005451.md) | [325](/filings/0001628280-25-023811.md) | [326](/filings/0001628280-25-036724.md) | [363](/filings/0001043219-25-000012.md) | [13.2 d](/filings/0001043219-26-000013.md) | [422](/filings/0001043219-26-000028.md) | [449](/filings/0001043219-26-000058.md) | [477](/filings/0001043219-25-000012.md) | [18.1 d](/filings/0001043219-26-000013.md) | [511](/filings/0001043219-26-000028.md) | [563](/filings/0001043219-26-000058.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [430](/filings/0001628280-23-036438.md) | [490](/filings/0001628280-24-020047.md) | [494](/filings/0001628280-24-033212.md) | [494](/filings/0001628280-24-044566.md) | [501](/filings/0001628280-25-023811.md) | [501](/filings/0001628280-25-036724.md) | [517](/filings/0001043219-25-000012.md) | [588](/filings/0001043219-26-000028.md) | [621](/filings/0001043219-26-000058.md) | [658](/filings/0001043219-25-000012.md) | [724](/filings/0001043219-26-000028.md) | [740](/filings/0001043219-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 753,714,442 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001043219-26-000058.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.